NCT03809039View on ClinicalTrials.gov

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of MT-6345 in Healthy Subjects

PHASE1TerminatedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

January 15, 2019

Primary Completion Date

July 1, 2019

Study Completion Date

July 1, 2020

Conditions
Healthy
Interventions
DRUG

MT-6345

MT-6345

DRUG

MT-6345 Placebo

MT-6345 Placebo

Trial Locations (1)

Unknown

Investigational center, City Name

Sponsors
All Listed Sponsors
lead

Mitsubishi Tanabe Pharma America Inc.

INDUSTRY